Home › Funds › IRIDIAN ASSET MANAGEMENT LLC/CT › ELV

IRIDIAN ASSET MANAGEMENT LLC/CT position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

IRIDIAN ASSET MANAGEMENT LLC/CT reported holding 10,252 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$4.0M, representing 1.45% of its reported portfolio and ranking #20 among its reported holdings. IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.25K sh
Reported value held$3.99M
Portfolio Weight1.45%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How IRIDIAN ASSET MANAGEMENT LLC/CT's ELV position evolved

IRIDIAN ASSET MANAGEMENT LLC/CT first disclosed a stake in ELV in Q3 2023 at 54,687 shares (US$23.8M). Across 13 filings, IRIDIAN ASSET MANAGEMENT LLC/CT increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 10,252 shares valued at US$4.0M — a reduction of -4,737 shares quarter over quarter.. Notable position changes include a 54% increase in Q4 2024 (shares rose 18% over the following quarter), a 52% trim in Q4 2025 (shares fell 16% over the following quarter), a 32% trim in Q3 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 54.69K $23.81M New
Q4 2023 44.42K $20.94M Reduce
Q1 2024 39.71K $20.59M Reduce
Q2 2024 35.37K $19.16M Reduce
Q3 2024 39.15K $20.36M Add
Q4 2024 60.20K $22.21M Add
Q1 2025 51.99K $22.61M Reduce
Q2 2025 46.62K $18.13M Reduce
Q3 2025 52.10K $16.84M Add
Q4 2025 25.07K $8.79M Reduce
Q1 2026 21.62K $6.33M Reduce
Q2 2026 14.99K $5.80M Reduce
Q3 2026 10.25K $3.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has IRIDIAN ASSET MANAGEMENT LLC/CT held ELV?

IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is IRIDIAN ASSET MANAGEMENT LLC/CT's current position in ELV?

As of Q3 2026, IRIDIAN ASSET MANAGEMENT LLC/CT holds 10.25K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $3.99M, representing 1.45% of its reported portfolio and ranking #20.

Has IRIDIAN ASSET MANAGEMENT LLC/CT been buying or selling ELV?

In the latest 13F filing (Q3 2026), IRIDIAN ASSET MANAGEMENT LLC/CT reduced its position in ELV.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.